Brødkrumme Forside ZIARCO Pharma ZIARCO Pharma Developed dermatological drugs, the lead being an H4 receptor antagonist tested in Atopic Dermatitis and Psoriasis patients. Lundbeckfonden BioCapital Investeringsår 2014 Acquired by Novartis in 2016 Lokation San Francisco, California, USA